January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 14, 2025

Allergic Multimorbidity Linked to Mucosal Healing in UC

Patients with 3+ allergic conditions had 8x higher odds of achieving mucosal healing, highlighting potential shared immune pathways.

Conexiant

January 07, 2025

Quirky Clinic: Regrowing Tonsils, Plastic-Infused Tea, & More

Can tonsils grow back? Are we drinking billions of nanoplastics in the name of wellness? Is fungi in the nose the culprit to sniffles? We explore these questions and more.

Conexiant

January 02, 2025

Glutamatergic Drugs Reduce OCD Symptoms, Study Shows

A meta-analysis suggests that glutamatergic medications significantly reduce obsessive-compulsive disorder symptoms but calls for further research due to study limitations.

Conexiant

December 23, 2024

Trump Team Targets Immediate WHO Exit, Experts Say

"I have it on good authority that he plans to withdraw, probably on Day One or very early in his administration."

Reuters

June 12, 2024

FAc Implant Shows Sustained Improvement in Uveitis

Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure.

Conexiant

July 02, 2024

Black Docs Lacking Amid Growing Attacks on Diversity Programs

Research has shown that patients of color prefer seeing doctors of their own race — and some studies have shown health outcomes are better for Black patients seeing Black doctors.

KFF Health News

June 06, 2024

Advances in Corneal Transplant Techniques

Explore new techniques in corneal transplantation, including Descemet’s membrane endothelial keratoplasty and artificial corneas, for treating corneal diseases.

Conexiant

June 10, 2024

Oral Sebetralstat Shows Efficacy in Treating HAE Attacks

Phase 3 trial shows oral sebetralstat significantly improves symptom relief and attack resolution in hereditary angioedema patients.

Conexiant